Kobe (Japan), Marcy l'Etoile (France) - July 2, 2007. Sysmex Corporation (HQ: Kobe, Japan; President: Hisashi Ietsugu) and bioMérieux (Euronext: BIM) have signed an agreement today by which bioMérieux will become Sysmex’s global partner for distributing its UF-1000i urinalysis system in microbiology laboratories.
Canada
All news
MNA Rizqy and Minister Fitzgibbon honor the employees of bioMérieux Canada Inc. with the National Assembly Medal for their exceptional contribution during the COVID-19 pandemic
27 June, 2022The bioMérieux Canada team remained true to its commitment towards public health by ensuring the installation of the BIOFIRE® systems in record time. The team traveled across Canada despite the sanitary restrictions to ensure adequate user training and was able to demonstrate agility and innovation...
Sysmex and bioMérieux Form a Global Partnership
02 July, 2007
Healthcare-Associated Infections : First World Forum on a critical public health issue
30 May, 2007
bioMérieux organizes the First World Forum on Healthcare-Associated Infections (HAI). This Forum will bring together around fifty international experts at the Mérieux Foundation Conference Center (Les Pensières, Veyrier-du-Lac, France) from June 4th to 5th 2007.
AdvanDx and bioMérieux Partner to Provide Rapid Results for Bloodstream Infections
22 May, 2007
In order to provide faster identification of bloodstream pathogens, bioMérieux (Euronext: BIM) has agreed with AdvanDx, Inc. to sign an exclusive distribution agreement for the United States for AdvanDx’s PNA FISH™ rapid diagnostic tests. These tests will be displayed at bioMérieux’s booth from the opening of the American Society of Microbiology (ASM) in Toronto on May 22.
bioMérieux Launches a Molecular Biology Test for the Detection of HPV, a Major Cause of Cervical Cancer
23 April, 2007
bioMérieux (Euronext: BIM) announces the launch of its NucliSENS EasyQ® HPV; this molecular diagnostic test enables the detection of human papillomavirus (HPV) in cervical cancer surveillance.
bioMérieux and LabTech Systems sign exclusive worldwide license agreement for innovative robotic microbiological instrumentation
18 April, 2007
LabTech Systems Ltd (ASX: LBT), an Australian health care equipment and services company, and bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, announced today that they have signed an exclusive worldwide license agreement for LabTech Systems’ automated pre-poured media (PPM) streaker known as MicroStreak®.
bioMérieux Innovates Further in the Fight against AIDSThe company Launches a Rapid Test, VIKIA® HIV 1 / 2
05 April, 2007
A world leader in the field of in vitro diagnostics, bioMérieux confirms its constant commitment to the fight against AIDS with the launch of VIKIA® HIV 1 / 2, a rapid test for the detection of HIV infection in human serum, plasma or whole and capillary blood.